Global GLP-1 Receptor Agonist Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18750091

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18750091

Global GLP-1 Receptor Agonist Databank Market Report

The GLP-1 Receptor Agonist market was valued at $12,315.6 Million in 2022, and is projected to reach $18,032.2 Million by 2031 growing at a CAGR of 4.37% from 2023 to 2031. Trulicity segment is expected to be the highest contributor to this market, with $6,373.8 Million in 2022, and is anticipated to reach $8,941.5 Million by 2031, registering a CAGR of 3.87%. Victoza segment is anticipated to reach $1,498.9 Million by 2031 with the highest CAGR of 7.27%. Trulicity and Ozempic segments collectively expected to account for about 66.7% share of the GLP-1 Receptor Agonist market in 2022, with the former constituting around 51.8% share. Victoza and Bydureon segments are expected to witness significant growth rates at a CAGR of 7.27% and 7.16% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 10.2% in the overall GLP-1 Receptor Agonist market in 2022, and is anticipated to reach 13.1% by 2031.

1. Global GLP-1 Receptor Agonist Market, By Product: 1.1. Overview; 1.2. Victoza; 1.2.1 Victoza Market, By Region; 1.2.1.1 North America Victoza Market, By Country; 1.2.1.2 Europe Victoza Market, By Country; 1.2.1.3 Asia-Pacific Victoza Market, By Country; 1.2.1.4 Rest of World Victoza Market, By Country; 1.3. Ozempic; 1.3.1 Ozempic Market, By Region; 1.3.1.1 North America Ozempic Market, By Country; 1.3.1.2 Europe Ozempic Market, By Country; 1.3.1.3 Asia-Pacific Ozempic Market, By Country; 1.3.1.4 Rest of World Ozempic Market, By Country; 1.4. Trulicity; 1.4.1 Trulicity Market, By Region; 1.4.1.1 North America Trulicity Market, By Country; 1.4.1.2 Europe Trulicity Market, By Country; 1.4.1.3 Asia-Pacific Trulicity Market, By Country; 1.4.1.4 Rest of World Trulicity Market, By Country; 1.5. Bydureon; 1.5.1 Bydureon Market, By Region; 1.5.1.1 North America Bydureon Market, By Country; 1.5.1.2 Europe Bydureon Market, By Country; 1.5.1.3 Asia-Pacific Bydureon Market, By Country; 1.5.1.4 Rest of World Bydureon Market, By Country; 1.6. Saxenda; 1.6.1 Saxenda Market, By Region; 1.6.1.1 North America Saxenda Market, By Country; 1.6.1.2 Europe Saxenda Market, By Country; 1.6.1.3 Asia-Pacific Saxenda Market, By Country; 1.6.1.4 Rest of World Saxenda Market, By Country; 1.7. Other Products; 1.7.1 Other Products Market, By Region; 1.7.1.1 North America Other Products Market, By Country; 1.7.1.2 Europe Other Products Market, By Country; 1.7.1.3 Asia-Pacific Other Products Market, By Country; 1.7.1.4 Rest of World Other Products Market, By Country
2. Global GLP-1 Receptor Agonist Market, By Region: 2.1. Overview; 2.2. North America; 2.2.1 North America GLP-1 Receptor Agonist Market, By Product; 2.2.2 North America GLP-1 Receptor Agonist Market, By Country; 2.2.2.1 U.S.; 2.2.2.1.1 U.S. GLP-1 Receptor Agonist Market, By Product; 2.2.2.2 Canada; 2.2.2.2.1 Canada GLP-1 Receptor Agonist Market, By Product; 2.3. Europe; 2.3.1 Europe GLP-1 Receptor Agonist Market, By Product; 2.3.2 Europe GLP-1 Receptor Agonist Market, By Country; 2.3.2.1 Germany; 2.3.2.1.1 Germany GLP-1 Receptor Agonist Market, By Product; 2.3.2.2 U.K.; 2.3.2.2.1 U.K. GLP-1 Receptor Agonist Market, By Product; 2.3.2.3 France; 2.3.2.3.1 France GLP-1 Receptor Agonist Market, By Product; 2.3.2.4 Italy; 2.3.2.4.1 Italy GLP-1 Receptor Agonist Market, By Product; 2.3.2.5 Spain; 2.3.2.5.1 Spain GLP-1 Receptor Agonist Market, By Product; 2.3.2.6 Rest of Europe; 2.3.2.6.1 Rest of Europe GLP-1 Receptor Agonist Market, By Product; 2.4. Asia-Pacific; 2.4.1 Asia-Pacific GLP-1 Receptor Agonist Market, By Product; 2.4.2 Asia-Pacific GLP-1 Receptor Agonist Market, By Country; 2.4.2.1 China; 2.4.2.1.1 China GLP-1 Receptor Agonist Market, By Product; 2.4.2.2 Japan; 2.4.2.2.1 Japan GLP-1 Receptor Agonist Market, By Product; 2.4.2.3 South Korea; 2.4.2.3.1 South Korea GLP-1 Receptor Agonist Market, By Product; 2.4.2.4 India; 2.4.2.4.1 India GLP-1 Receptor Agonist Market, By Product; 2.4.2.5 Singapore; 2.4.2.5.1 Singapore GLP-1 Receptor Agonist Market, By Product; 2.4.2.6 Rest of Asia; 2.4.2.6.1 Rest of Asia GLP-1 Receptor Agonist Market, By Product; 2.5. Rest of World; 2.5.1 Rest of World GLP-1 Receptor Agonist Market, By Product; 2.5.2 Rest of World GLP-1 Receptor Agonist Market, By Country; 2.5.2.1 Brazil; 2.5.2.1.1 Brazil GLP-1 Receptor Agonist Market, By Product; 2.5.2.2 Mexico; 2.5.2.2.1 Mexico GLP-1 Receptor Agonist Market, By Product; 2.5.2.3 South Africa; 2.5.2.3.1 South Africa GLP-1 Receptor Agonist Market, By Product; 2.5.2.4 Australia; 2.5.2.4.1 Australia GLP-1 Receptor Agonist Market, By Product; 2.5.2.5 ROW Countries; 2.5.2.5.1 ROW Countries GLP-1 Receptor Agonist Market, By Product; ROW Countries GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 2. Victoza Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America Victoza Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe Victoza Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific Victoza Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World Victoza Market Value, By Country, 2022-2031, Million USD; TABLE 7. Ozempic Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Ozempic Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Ozempic Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Ozempic Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Ozempic Market Value, By Country, 2022-2031, Million USD; TABLE 12. Trulicity Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America Trulicity Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe Trulicity Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific Trulicity Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World Trulicity Market Value, By Country, 2022-2031, Million USD; TABLE 17. Bydureon Market Value, By Region, 2022-2031, Million USD; TABLE 18. North America Bydureon Market Value, By Country, 2022-2031, Million USD; TABLE 19. Europe Bydureon Market Value, By Country, 2022-2031, Million USD; TABLE 20. Asia-Pacific Bydureon Market Value, By Country, 2022-2031, Million USD; TABLE 21. Rest of World Bydureon Market Value, By Country, 2022-2031, Million USD; TABLE 22. Saxenda Market Value, By Region, 2022-2031, Million USD; TABLE 23. North America Saxenda Market Value, By Country, 2022-2031, Million USD; TABLE 24. Europe Saxenda Market Value, By Country, 2022-2031, Million USD; TABLE 25. Asia-Pacific Saxenda Market Value, By Country, 2022-2031, Million USD; TABLE 26. Rest of World Saxenda Market Value, By Country, 2022-2031, Million USD; TABLE 27. Other Products Market Value, By Region, 2022-2031, Million USD; TABLE 28. North America Other Products Market Value, By Country, 2022-2031, Million USD; TABLE 29. Europe Other Products Market Value, By Country, 2022-2031, Million USD; TABLE 30. Asia-Pacific Other Products Market Value, By Country, 2022-2031, Million USD; TABLE 31. Rest of World Other Products Market Value, By Country, 2022-2031, Million USD; TABLE 32. Global GLP-1 Receptor Agonist Market Value, By Region, 2022-2031, Million USD; TABLE 33. North America GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 34. North America GLP-1 Receptor Agonist Market Value, By Country, 2022-2031, Million USD; TABLE 35. U.S. GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 36. Canada GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 37. Europe GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 38. Europe GLP-1 Receptor Agonist Market Value, By Country, 2022-2031, Million USD; TABLE 39. Germany GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 40. U.K. GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 41. France GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 42. Italy GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 43. Spain GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 44. Rest of Europe GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 45. Asia-Pacific GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 46. Asia-Pacific GLP-1 Receptor Agonist Market Value, By Country, 2022-2031, Million USD; TABLE 47. China GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 48. Japan GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 49. South Korea GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 50. India GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 51. Singapore GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 52. Rest of Asia GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 53. Rest of World GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 54. Rest of World GLP-1 Receptor Agonist Market Value, By Country, 2022-2031, Million USD; TABLE 55. Brazil GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 56. Mexico GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 57. South Africa GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 58. Australia GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; TABLE 59. ROW Countries GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD; ROW Countries GLP-1 Receptor Agonist Market Value, By Product, 2022-2031, Million USD